News
Home > News > News
- 2024/11/28The company obtained US patent: PREPARATION METHOD OF TRILACICLIB
- 2024/11/22The company accomplished CCSBpofungin & Tacrolimus audit.
- 2024/10/31The company accomplished Tacrolimus audit.
- 2024/10/23The company accomplished Trandolapril audit.
- 2024/09/12The company accomplished Methocarbamol remote audit.
- 2024/08/29CCSB accomplished Rapamycin audit.
- 2024/05/17CCSB accomplished Mycophenolate Mofetil audit.
- 2024/04/30CCSB accomplished Ethyl Icosapentate, Everolimus, etc. audit
- 2024/04/26CCSB accomplished Methocarbamol audit.
- 2024/04/12CCSB accomplished an inspection of The Food and Drug Administration (USFDA).
